Ampicillin
Half-Life (t½) IV: 1h · PO: 1.45h
Formula C16H19N3O4S
Molecular Weight 349.41 g/mol Pharmacological Mechanism Aminopenicillin β-lactam — broader spectrum than penicillin (adds Listeria, Enterococcus, some gram-negatives). IV use in meningitis empiric coverage + Listeria-targeted therapy in elderly + immunocompromised. Renal-cleared.
Half-Life & Elimination Curve (IV: 1h · PO: 1.45h) 100% 50% 25% 12.5% 0% 0h 0×t½ 1.45h 1×t½ 2.9h 2×t½ 4.35h 3×t½ 5.8h 4×t½ 7.25h 5×t½ 0×t½ (0h): 100% remaining (~9.69 mg/L) 1×t½ (1.45h): 50% remaining (~4.84 mg/L) 2×t½ (2.9h): 25% remaining (~2.42 mg/L) 3×t½ (4.35h): 12.5% remaining (~1.21 mg/L) 4×t½ (5.8h): 6.3% remaining (~0.606 mg/L) 5×t½ (7.25h): 3.1% remaining (~0.303 mg/L) Plasma (PO) t½ Decay (1.45h)
0×t½ 0h 100% (9.69 mg/L) 1×t½ 1.45h 50% (4.84 mg/L) 2×t½ 2.9h 25% (2.42 mg/L) 3×t½ 4.35h 12.5% (1.21 mg/L) 4×t½ 5.8h 6.3% (0.606 mg/L) 5×t½ 7.25h 3.1% (0.303 mg/L) Dosing Guidelines Intravenous (IV): Typical 1000 mg (Range: 250–2000 mg)Pharmacokinetic Parameters Oral (PO): Bioavailability (F): 40% · Volume of Distribution (Vd): 21 L · Absorption (ka): 1 h⁻¹ (t½ka ≈ 42m) [PMID 6313357 ]Intravenous (IV): Bioavailability (F): 100% · Volume of Distribution (Vd): 21 L [PMID 6313357 ]Pathways It Modulates Target Organ Systems Chemical Structure & Identifiers InChIKey: AVKUERGKIZMTKX-NJBDSQKTSA-NSMILES: CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)N)C(=O)O)CReferences Directory Compounds Registry Human Biology Hub